Annie Froehlich

Partner
Full contact info

Experience

Everbridge Enters Into Definitive Agreement to Be Acquired by Thoma Bravo for $1.5 Billion

February 5, 2024

Cooley advised Everbridge, a global leader in critical event management and national public warning solutions, on its definitive agreement to be acquired by Thoma Bravo in an all-cash transaction valuing Everbridge at approximately $1.5 billion.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Kevin Cooper
Partner, New York
Polina A. Demina
Associate, New York
C. Thomas Hopkins
Partner, Los Angeles Santa Monica
Brad Goldberg
Partner, New York
Mischi a Marca
Partner, San Francisco
Caitlin Courtney
Partner, Palo Alto
Michael Egan
Partner, Washington, DC
David Fletcher
Partner, Washington, DC
Annie Froehlich
Partner, Washington, DC
Patrick Flanagan
Partner, New York
Stephanie Gentile
Partner, New York
Christopher Kimball
Partner, Washington, DC
Barbara Mirza
Partner, Los Angeles Santa Monica
Howard Morse
Partner, Washington, DC
Miriam Petrillo
Partner, Chicago
Jason Savich
Partner, San Francisco
Michael C. Tu
Partner, Los Angeles Downtown
Dillon Martinson
Special Counsel, Washington, DC
Stella Sarma
Special Counsel, Brussels
Grant Schweikert
Special Counsel, Washington, DC
Umer Chaudhry
Associate, Washington, DC
Katherine Denby
Associate, Washington, DC
Alexander Ellebracht
Associate, Palo Alto
Athina Gaki
Associate, Brussels
Carly E. Gibbons
Associate, Chicago
Daniel Han
Associate, New York
Gary Warren Hunt III
Associate, Washington, DC
Alexandra Leavy
Associate, New York
Jeewon Lee
Associate, New York
Morgan Lloyd
Associate, New York
Joe Mandry
Associate, San Diego
Matthew S. Scarano
Associate, San Diego
Ben Sweeney
Associate, Los Angeles Downtown
Mickeala Tu
Associate, Palo Alto
Genevieve Lim Urban
Associate, Seattle
Rubin Waranch
Associate, Washington, DC
Lois NaYeon Yoo
Associate, New York

Related Practices & Industries

COUR Pharmaceuticals Secures $105 Million Series A

January 30, 2024

Cooley advised COUR Pharmaceuticals, a clinical-stage biotechnology company focused on the development of first-in-class disease-modifying therapies designed to induce antigen-specific tolerance for immune-mediated diseases, on the close of its $105 million Series A financing.

Read more

Related contacts

Winston Gu
Partner, Chicago
Marc Recht
Partner, Boston
Christina T. Roupas
Partner in Charge – Chicago, Chicago
Yvan-Claude Pierre
Partner, New York
Joyce Kim
Associate, Chicago
Grant L. Page
Associate, Los Angeles Santa Monica
Andrew Mettry
Associate, Chicago
Jeffrey J. Tolin
Partner, New York
Blake Martell
Partner, San Francisco
John Sellers
Partner, Palo Alto
Alan W. Tamarelli
Partner, New York
Bin Wang
Special Counsel, Palo Alto
Annie Froehlich
Partner, Washington, DC
Erica Russell
Associate, San Francisco
Calvin Lee
Associate, New York
Andrew Bae
Associate, Washington, DC
Zack Gong
Associate, Shanghai
Miriam Petrillo
Partner, Chicago

Related Practices & Industries

Blue Owl Capital Invests up to $140 Million in XOMA Corporation

December 19, 2023

Cooley advised Blue Owl Capital, a top asset manager that is redefining alternatives, on its strategic investment – consisting of a nondilutive, nonrecourse royalty-backed loan of up to $140 million – in XOMA Corporation, a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health.

Read more

Related contacts

Michael Tollini
Partner, Washington, DC
Mischi a Marca
Partner, San Francisco
Addison Pierce
Associate, Chicago
Xander Lee
Partner, Los Angeles Santa Monica
Geoffrey Spolyar
Partner, Boston
Ivor Elrifi
Partner, New York
Michael Klein
Partner, New York
Annie Froehlich
Partner, Washington, DC
Yichao Zhang
Associate, New York
Xueqing Li
Associate, San Francisco
Patrick Sharma
Associate, Los Angeles Santa Monica
Cameron Hajialiakbar
Associate, Los Angeles Santa Monica
Evan Lazerowitz
Associate, New York
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries

SystImmune Announces Global Strategic Collaboration With Bristol Myers Squibb

December 11, 2023

Cooley advised SystImmune, a clinical-stage biopharmaceutical company, on its exclusive license and collaboration agreement with Bristol Myers Squibb for SystImmune’s BL-B01D1.

Read more

Related contacts

Kate Hillier
Partner, Seattle
Lila Hope
Partner, Palo Alto
Chen Chen
Partner, Boston
Aaron Pomeroy
Partner, Colorado
Todd Gluth
Partner, San Diego
Rick Jantz
Associate, Los Angeles Santa Monica
Jonathan Kaufman
Associate, Palo Alto
Zack Gong
Associate, Shanghai
Rena Kaminsky
Special Counsel, Palo Alto
Freddy Yip
Associate, Hong Kong
David D. Suh
Associate, Palo Alto
David Burns
Special Counsel, Washington, DC
Rubin Waranch
Associate, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Daniel Millard
Associate, London
Zhijing Yu
Associate, Singapore
Rachel Thorn
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Christopher Kimball
Partner, Washington, DC
Dillon Martinson
Special Counsel, Washington, DC
Annie Froehlich
Partner, Washington, DC

Related Practices & Industries

Carmot Therapeutics Enters Definitive Merger Agreement With Roche

December 3, 2023

Cooley advised Carmot Therapeutics, a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases including obesity and diabetes, on its definitive merger agreement in which Roche will acquire Carmot.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Charity Williams
Partner, San Diego
David Peinsipp
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Lauren Creel
Partner, Palo Alto
Howard Morse
Partner, Washington, DC
Xander Lee
Partner, Los Angeles Santa Monica
Kathleen O'Neill
Partner, Washington, DC
Ross Eberly
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
TJ Graham
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Tracy Rubin
Partner, Palo Alto
Phil Mitchell
Partner, New York
Charlie Kim
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Christine Graham
Special Counsel, London
Stella Sarma
Special Counsel, Brussels
J. Brian Stalter
Special Counsel, New York
Jennifer Shanley
Special Counsel, New York
Grant Schweikert
Special Counsel, Washington, DC
Kristopher Kleiner
Special Counsel, Colorado
Dani Nazemian
Special Counsel, San Diego
Annie Froehlich
Partner, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
Sangitha Palaniappa
Associate, Palo Alto
Tyler McClure
Associate, San Francisco
Rubin Waranch
Associate, Washington, DC
Melissa Meza
Associate, San Diego
Jameson Davis
Associate, Palo Alto
Alexander Ellebracht
Associate, Palo Alto
Mor Agam
Associate, New York
Athina Gaki
Associate, Brussels
Andy Zachrich
Associate, San Diego
Dionne A. Thomas
Associate, San Diego
Umer Chaudhry
Associate, Washington, DC
Jane Jun
Associate, Palo Alto
Samara Zaifman
Associate, Palo Alto
Carly E. Gibbons
Associate, Chicago
Claire Norman
Associate, Palo Alto
Anitha Anne
Associate, San Francisco
Kristina Krasnikova
Associate, Palo Alto
Patricia Myers
Paralegal Specialist, Colorado
Loraine Torres
Paralegal Specialist, Colorado
Hitesh Patel
eDiscovery Attorney, Washington, DC

Related Practices & Industries

View more

Memberships & affiliations

Atlantic Council, Nonresident Senior Fellow

Association of Women in International Trade